370 related articles for article (PubMed ID: 20824132)
1. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.
Handel AE; Williamson AJ; Disanto G; Handunnetthi L; Giovannoni G; Ramagopalan SV
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824132
[TBL] [Abstract][Full Text] [Related]
2. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis.
Thacker EL; Mirzaei F; Ascherio A
Ann Neurol; 2006 Mar; 59(3):499-503. PubMed ID: 16502434
[TBL] [Abstract][Full Text] [Related]
3. Association of Infectious Mononucleosis in Childhood and Adolescence With Risk for a Subsequent Multiple Sclerosis Diagnosis Among Siblings.
Xu Y; Hiyoshi A; Smith KA; Piehl F; Olsson T; Fall K; Montgomery S
JAMA Netw Open; 2021 Oct; 4(10):e2124932. PubMed ID: 34633426
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis.
Lindberg C; Andersen O; Vahlne A; Dalton M; Runmarker B
Neuroepidemiology; 1991; 10(2):62-5. PubMed ID: 2062419
[TBL] [Abstract][Full Text] [Related]
5. Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study.
Lossius A; Riise T; Pugliatti M; Bjørnevik K; Casetta I; Drulovic J; Granieri E; Kampman MT; Landtblom AM; Lauer K; Magalhaes S; Myhr KM; Pekmezovic T; Wesnes K; Wolfson C; Holmøy T
Mult Scler; 2014 May; 20(6):669-74. PubMed ID: 24072723
[TBL] [Abstract][Full Text] [Related]
6. Risk of multiple sclerosis in individuals with infectious mononucleosis: a national population-based cohort study using hospital records in England, 2003-2023.
Goldacre R
Mult Scler; 2024 Apr; 30(4-5):489-495. PubMed ID: 38511730
[TBL] [Abstract][Full Text] [Related]
7. Infectious mononucleosis and multiple sclerosis - Updated review on associated risk.
Sheik-Ali S
Mult Scler Relat Disord; 2017 May; 14():56-59. PubMed ID: 28619433
[TBL] [Abstract][Full Text] [Related]
8. Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?
Mameli G; Madeddu G; Mei A; Uleri E; Poddighe L; Delogu LG; Maida I; Babudieri S; Serra C; Manetti R; Mura MS; Dolei A
PLoS One; 2013; 8(11):e78474. PubMed ID: 24236019
[TBL] [Abstract][Full Text] [Related]
9. Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.
Bjørnevik K; Riise T; Bostrom I; Casetta I; Cortese M; Granieri E; Holmøy T; Kampman MT; Landtblom AM; Magalhaes S; Pugliatti M; Wolfson C; Myhr KM
Mult Scler; 2017 Jun; 23(7):1018-1024. PubMed ID: 27663872
[TBL] [Abstract][Full Text] [Related]
10. Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis?
Mameli G; Madeddu G; Cossu D; Galleri G; Manetti R; Babudieri S; Mura MS; Sechi LA
Eur J Neurol; 2016 Jan; 23(1):140-7. PubMed ID: 26453465
[TBL] [Abstract][Full Text] [Related]
11. Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors.
Jacobs BM; Giovannoni G; Cuzick J; Dobson R
Mult Scler; 2020 Oct; 26(11):1281-1297. PubMed ID: 32202208
[TBL] [Abstract][Full Text] [Related]
12. Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study.
Gustavsen MW; Page CM; Moen SM; Bjølgerud A; Berg-Hansen P; Nygaard GO; Sandvik L; Lie BA; Celius EG; Harbo HF
BMC Neurol; 2014 Oct; 14():196. PubMed ID: 25274070
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis after infectious mononucleosis.
Nielsen TR; Rostgaard K; Nielsen NM; Koch-Henriksen N; Haahr S; Sørensen PS; Hjalgrim H
Arch Neurol; 2007 Jan; 64(1):72-5. PubMed ID: 17210811
[TBL] [Abstract][Full Text] [Related]
14. Smoking and Epstein-Barr virus infection in multiple sclerosis development.
Hedström AK; Huang J; Brenner N; Butt J; Hillert J; Waterboer T; Kockum I; Olsson T; Alfredsson L
Sci Rep; 2020 Jul; 10(1):10960. PubMed ID: 32620875
[TBL] [Abstract][Full Text] [Related]
15. Obesity interacts with infectious mononucleosis in risk of multiple sclerosis.
Hedström AK; Lima Bomfim I; Hillert J; Olsson T; Alfredsson L
Eur J Neurol; 2015 Mar; 22(3):578-e38. PubMed ID: 25530445
[TBL] [Abstract][Full Text] [Related]
16. Association of infectious mononucleosis with multiple sclerosis. A population-based study.
Ramagopalan SV; Valdar W; Dyment DA; DeLuca GC; Yee IM; Giovannoni G; Ebers GC; Sadovnick AD;
Neuroepidemiology; 2009; 32(4):257-62. PubMed ID: 19209005
[TBL] [Abstract][Full Text] [Related]
17. Follow-up after infectious mononucleosis in search of serological similarities with presymptomatic multiple sclerosis.
Jons D; Persson Berg L; Sundström P; Haghighi S; Axelsson M; Thulin M; Bergström T; Andersen O
Mult Scler Relat Disord; 2021 Nov; 56():103288. PubMed ID: 34634626
[TBL] [Abstract][Full Text] [Related]
18. Season of infectious mononucleosis as a risk factor for multiple sclerosis: A UK primary care case-control study.
Downham C; Visser E; Vickers M; Counsell C
Mult Scler Relat Disord; 2017 Oct; 17():103-106. PubMed ID: 29055437
[TBL] [Abstract][Full Text] [Related]
19. Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis.
Nielsen TR; Rostgaard K; Askling J; Steffensen R; Oturai A; Jersild C; Koch-Henriksen N; Sørensen PS; Hjalgrim H
Mult Scler; 2009 Apr; 15(4):431-6. PubMed ID: 19153174
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal immunoreactivity in people with or without previous infectious mononucleosis.
Jons D; Zetterberg H; Malmeström C; Bergström T; Axelsson M; Blennow K; Thulin M; Sundström P; Andersen O
Acta Neurol Scand; 2020 Aug; 142(2):161-168. PubMed ID: 32415852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
